Price
$1.15
Decreased by -0.04%
Dollar Volume (20D)
69.96 K
ADR%
7.82
Earnings Report Date (estimate)
Aug 11, 23 (N/A)
Market Cap.
89.88 M
Shares Float
23.56 M
Shares Outstanding
78.16 M
Beta
0.00
Price / Earnings
-6.39
BPR
41.51
20D Range
1.12 1.50
50D Range
1.03 1.65
200D Range
0.86 7.29
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
May 12, 23 -0.18 -0.22
Increased by +82.64%
Mar 7, 23 -0.72 -0.31
Decreased by -426.64%
Nov 14, 22 0.76 -0.25
Increased by +1.62 K%
Nov 10, 22 0.76 -0.25
Increased by +1.62 K%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 23 113.00 K
Increased by +71.21%
-22.93 M
Decreased by -4.96%
Decreased by -20.29 K%
Increased by +38.70%
Dec 31, 22 111.00 K
Decreased by -31.06%
-16.82 M
Increased by +15.00%
Decreased by -15.15 K%
Decreased by -23.28%
Sep 30, 22 82.00 K
Decreased by -47.10%
131.47 M
Increased by +825.33%
Increased by +160.33 K%
Increased by +1.47 K%
Jun 30, 22 64.00 K
Increased by +N/A%
-22.45 M
Decreased by -15.70 M%
Decreased by -35.08 K%
Decreased by N/A%
Mar 31, 22 66.00 K
Decreased by -34.00%
-21.84 M
Decreased by -186.49%
Decreased by -33.09 K%
Decreased by -334.07%
Dec 31, 21 161.00 K - -19.78 M -
Decreased by -12.29 K%
-
Sep 30, 21 155.00 K - -18.13 M -
Decreased by -11.69 K%
-
Jun 30, 21 0.00 - -143.00 -
Decreased by N/A%
-
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.